Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > November 10, 2020
Daily News
November 10, 2020
- AnGes to Buy US Gene Editing Therapeutics Firm Emendo
November 10, 2020
- MHLW Says to Publish PAFSC Minutes for COVID-19 Vaccines in 3 Weeks, but Opposition Parties Unimpressed
November 10, 2020
- Public-Private Confab Set for November 16; Pro-Innovation Measures Up for Discussion
November 10, 2020
- Incyte Gearing Up for Solo Marketing in Japan, Set to Double Workforce to 70 Staffers
November 10, 2020
- Ono/BMS Sign Patent License Deal for Tecentriq with Roche
November 10, 2020
- Japan Ethical Drug Sales Drop 9.6% in September: Crecon
November 10, 2020
- Japan to Set New Technical Fee for CureApp’s Quit Smoking App
November 10, 2020
- Ono Launches Japan PIII Study for Foipan for COVID-19
November 10, 2020
- MHLW Unveils Draft Ordinance for Electronic Distribution of Package Inserts; Use of GS1 Codes Expected
November 10, 2020
Japan’s pharmaceutical industry is undergoing a structural shift in its workforce, with the role of sales reps shrinking while production…
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…